Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (401-410 of 495) with videos related to

Pageof 50
Sort By:
Pathology, Research and Practice|March 7, 2024
Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumorsFrank Jacobsen, Ramesh Pushpadevan, Florian Viehweger, et al.
Histology and Histopathology|June 1, 2022
DOG1 overexpression is associated with mismatch repair deficiency and BRAF mutations but unrelated to cancer progression in colorectal cancerKristina Jansen, Martina Kluth, Niclas C Blessin, et al.
Virchows Archiv : an International Journal of Pathology|September 24, 2021
Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implicationsCosima Völkel, Noémi De Wispelaere, Sören Weidemann, et al.
Molecular Medicine (Cambridge, Mass.)|March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionChristoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Molecular Carcinogenesis|September 24, 2019
A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancerSimon Kind, Annika Jaretzke, Franziska Büscheck, et al.
Archives of Pathology & Laboratory Medicine|August 2, 2022
SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 TumorsDavid Dum, Daniela Kromm, Maximilian Lennartz, et al.
Annals of Diagnostic Pathology|August 23, 2021
Immunohistochemically detectable thyroglobulin expression in extrathyroidal cancer is 100% specific for thyroidal tumor originStefan Steurer, Jana Schneider, Franziska Büscheck, et al.
Biomarker Research|January 26, 2021
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumorsStefan Steurer, Claudia Riemann, Franziska Büscheck, et al.
Technology in Cancer Research & Treatment|September 22, 2021
MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue SamplesSebastian Dwertmann Rico, Moritz Mahnken, Franziska Büscheck, et al.
BMC Cancer|October 14, 2019
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancerSören A Weidemann, Charlotte Sauer, Andreas M Luebke, et al.
Pageof 50

Showing results (401-410 of 495) with videos related to

Sort By:
Pageof 50
Pathology, Research and Practice|March 7, 2024
Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumorsFrank Jacobsen, Ramesh Pushpadevan, Florian Viehweger, et al.
Histology and Histopathology|June 1, 2022
DOG1 overexpression is associated with mismatch repair deficiency and BRAF mutations but unrelated to cancer progression in colorectal cancerKristina Jansen, Martina Kluth, Niclas C Blessin, et al.
Virchows Archiv : an International Journal of Pathology|September 24, 2021
Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implicationsCosima Völkel, Noémi De Wispelaere, Sören Weidemann, et al.
Molecular Medicine (Cambridge, Mass.)|March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionChristoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Molecular Carcinogenesis|September 24, 2019
A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancerSimon Kind, Annika Jaretzke, Franziska Büscheck, et al.
Archives of Pathology & Laboratory Medicine|August 2, 2022
SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 TumorsDavid Dum, Daniela Kromm, Maximilian Lennartz, et al.
Annals of Diagnostic Pathology|August 23, 2021
Immunohistochemically detectable thyroglobulin expression in extrathyroidal cancer is 100% specific for thyroidal tumor originStefan Steurer, Jana Schneider, Franziska Büscheck, et al.
Biomarker Research|January 26, 2021
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumorsStefan Steurer, Claudia Riemann, Franziska Büscheck, et al.
Technology in Cancer Research & Treatment|September 22, 2021
MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue SamplesSebastian Dwertmann Rico, Moritz Mahnken, Franziska Büscheck, et al.
BMC Cancer|October 14, 2019
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancerSören A Weidemann, Charlotte Sauer, Andreas M Luebke, et al.
Pageof 50